Adverse drug reaction or innocent bystander? A systematic comparison of statistical discovery methods for spontaneous reporting systems-Reference-Cited by-同舟云学术

Adverse drug reaction or innocent bystander? A systematic comparison of statistical discovery methods for spontaneous reporting systems

Published:2020-02-24 Issue:4 Volume:29 Page:396-403
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Dijkstra Louis¹^ORCID,Garling Marco²,Foraita Ronja¹,Pigeot Iris¹

Affiliation:

1. Leibniz Institute for Prevention Research & Epidemiology, BIPS, Achterstraße 30 28359 Bremen Germany

2. Scientific Institute of TK for Benefit & Efficiency in Health Care, WINEG Bramfelder Straße 140, 22305 Hamburg Germany

Funder

Federal Joint Committee in Germany

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4970

Reference29 articles.

1. Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events

2. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

3. WHO.The importance of pharmacovigilance: safety monitoring of medicinal products. Technical report 2002.http://apps.who.int/medicinedocs/pdf/s4893e/s4893e.pdf. Assessed 23 Aug 2018.

4. Adverse drug event reporting systems: a systematic review

5. A Comparison of Active Adverse Event Surveillance Systems Worldwide

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A discovery and verification approach to pharmacovigilance using electronic healthcare data;Frontiers in Pharmacology;2024-09-04

2. Patientensicherheit im Innovationsfonds – Charakterisierung, Resultate und Bewertung abgeschlossener Projekte: Ergebnisse eines Scoping Reviews;Das Gesundheitswesen;2024-08-15

3. Safety of tildrakizumab: a disproportionality analysis based on the FDA adverse event reporting system (FAERS) database from 2018–2023;Frontiers in Pharmacology;2024-07-10

4. The evolving role of disproportionality analysis in pharmacovigilance;Expert Opinion on Drug Safety;2024-06-24

5. Adverse drug reaction signal detection methods in spontaneous reporting system: A systematic review;Pharmacoepidemiology and Drug Safety;2024-02-28